Back

Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Comorbidities in Heart Failure: What Could Be Done Better? Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Edouard Fu

Leiden University Medical Center, Leiden (Netherlands (The))

2 More presentations in this session

Presentation thumbnail
Myocardial iron depletion exacerbates end-stage heart failure by promoting adverse remodeling and worsening mitochondrial function
Doctor H. Zhang (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
New-onset type 2 diabetes in heart failure: impact of heart failure and death versus ischemic events - a danish nationwide cohort study.
Mrs B. Zareini (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities in Heart Failure: What Could Be Done Better?

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources